Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo dual modality contemporaneous imaging of different tumor reactive T-cell subpopulations
    Meeting Abstract

    Doubrovin, M. M.; Doubrovina, E. S.; Cai, S.; Blasberg, R. G.; O'Reilly, R. J.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Optimal combined modality treatment improves outcome of locally advanced bladder cancer: Analysis of SWOG 8710
    Meeting Abstract

    Dotan, Z. A.; Bajorin, D. F.; Grossman, B. H.; Herr, H. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • An estrogen receptor-negative breast cancer subset with over expression of hormone responsive genes
    Meeting Abstract

    Doane, A. S.; Danso, M. A.; Lal, P.; Donaton, M.; Zhang, L.; Hudis, C.; Gerald, W. L.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Complete heart block in a patient receiving combination antifungal therapy with voriconazole and caspofungin: Is there a link?
    Meeting Abstract

    Djurkovic, S.; Voigt, L.; Mcaleer, E.; Ross-Douglas, B.; Pastores, S. M.; Halpern, N. A.
    Chest (2005)

    Fulltext@MSK | Save
  • The multitargeted kinase inhibitor sunitinib malate (SU11248): Soluble protein biomarkers of pharmacodynamic activity in patients with metastatic renal cell cancer
    Meeting Abstract

    DePrimo, S.; Bello, C.; Smeraglia, J.; Shalinsky, D.; Freddo, J.; Baum, C.; Rini, R.; Michaelson, M.; Motzer, R.; Spinella, D.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Molecular and immunological studies of vaccinia virus infection in epidermal Langerhans cells
    Meeting Abstract

    Deng, L.; Ding, W.; Xiang, J. Z.; Granstein, R. D.; Shuman, S.
    Journal of Investigative Dermatology (2005)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy (IMRT) for advanced oropharyngeal carcinoma: The MSKCC experience
    Meeting Abstract

    De Arruda, F. F.; Zhung, J.; Narayana, A.; Wolden, S.; Pfister, D. G.; Serrano, V.; Kraus, D. H.; Shaha, A.; Shah, J.; Lee, N. Y.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) therapy in patients with unresectable primary liver cancer: Use of dynamic contrast enhanced MRI to evaluate response
    Meeting Abstract

    Danso, M.; Jarnagin, W. R.; Muruganandham, M.; Schwartz, L. H.; Gonen, M.; Haviland, D.; Blumgart, L.; D'Angelica, M.; DeMatteo, R.; Kemeny, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save